Clinical Trials

150 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT07562022 2026-05-01

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma

93 enrolled

Lymphoma, Follicular

NCT07516093 2026-04-08

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

620 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT07509151 2026-04-03

SOUNDTRACK-C1

420 enrolled

Leukemia, Lymphoma, Leukemia, B-Cell

NCT07476729 2026-03-17

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

750 enrolled

Burkitt Lymphoma

NCT07223190 2026-03-04

AUDAX

560 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07355283 2026-01-27

IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma

198 enrolled

Lymphoma, Follicular

NCT07321652 2026-01-07

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

466 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07256158 2025-12-09

FIL_PRIORITY

518 enrolled

Hodgkin Disease

NCT07215910 2025-10-14

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

408 enrolled

CNSLymphoid

Astrocytoma, Lymphoma, Follicular

NCT07187960 2025-09-23

Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma

228 enrolled

Lymphoma, Follicular

NCT07178457 2025-09-17

BeCALM

84 enrolled

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT07082452 2025-07-24

SEVENAZA

262 enrolled

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute

NCT06953739 2025-05-01

A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or Advanced-Stage ENKTL.

60 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT06673459 2024-11-05

BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients

430 enrolled

Leukemia, T-Cell

NCT06573645 2024-08-27

A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL

428 enrolled

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT06510530 2024-07-19

Astragalus for Symptomatic Alleviation in High-grade Lymphoma

60 enrolled

Lymphoma, Non-Hodgkin

NCT06434467 2024-05-30

The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma

83 enrolled

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05775705 2023-03-20

L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH

25 enrolled

LymphoidMyeloid

Lymphoma, Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic

NCT05205902 2022-01-25

TOTEM-01